tirzepatide surpass-5 Efficacy and safety of in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial SURMOUNT-5: Tirzepatide and semaglutide go

This month, two leading pharma companies expect to share data from their highly anticipated Phase 3 studies at the Clinical Trials on Alzheimers Disease conference

Adult obesity and health-related quality of life, patient activation, work productivity, and weight loss behaviors in the United States

At Flow Wellness, patients receive ongoing provider support, body composition monitoring, and treatment plans built around their goals to help maximize results while minimizing side effects during dose escalation

Patients with a personal or family history of MTC or MEN 2 should not use tirzepatide

Another says 50

Eli Lilly found compounded products contaminated with bacteria, containing incorrect substances, or manufactured with no active ingredient at all